Home » Topics » Regulatory

Regulatory
RSS

FDA gives go-ahead for Access to commence OraDisc clinical trials

April 5, 2000

Another indication for Enbrel will be discussed at advisory committee meeting

April 5, 2000

CollaGenex seeks FDA approval for new dosage form of Periostat

April 5, 2000

Avandia receives FDA approval for treatment of type II diabetes in combination with sulfonylureas

April 4, 2000

SmithKline Beecham claims 5-HT6 antagonists for ADHD

March 30, 2000

Organogenesis receives milestone payment related to Apligraf progress

March 30, 2000

Merck & Co. confirms study results of Singulair as allergic rhinitis treatment

March 29, 2000

Extensive review of novel cytoprotectant appears in supplementary issue of DOT

March 29, 2000

CPMP recommends approval of Kogenate Bayer as hemophilia A treatment

March 27, 2000

New study of Sandostatin for managing diarrhea to commence in the U.S. and Canada

March 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...